![](/img/cover-not-exists.png)
Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study
Philippe Moreau, Halyna Pylypenko, Sebastian Grosicki, Ievgenii Karamanesht, Xavier Leleu, Maria Grishunina, Grigoriy Rekhtman, Zvenyslava Masliak, Tadeusz Robak, Anna Shubina, Bertrand Arnulf, MartinVolume:
12
Year:
2011
Language:
english
DOI:
10.1016/s1470-2045(11)70081-x
File:
PDF, 247 KB
english, 2011